Clinical Trial Update: Denosumab and Nivolumab Combination As 2d-line Therapy in Stage IV NSC Lung Cancer with Bone Metastases (DENIVOS) [Phase 2]

View source ↗

Summary

Phase 2 DENIVOS trial evaluating the combination of denosumab and nivolumab as second-line therapy for stage IV non-small cell lung cancer with bone metastases …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Denosumab (denosumab)
• nivolumab (nivolumab)

Snippet

Sponsor: Centre Hospitalier Annecy Genevois | Conditions: Carcinoma, Non-Small-Cell Lung, Bone Metastases | Phase 2 | Status: COMPLETED